These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 32488563)

  • 1. Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma.
    Policiano C; Subirá J; Aguilar A; Monzó S; Iniesta I; Rubio Rubio JM
    J Assist Reprod Genet; 2020 Jul; 37(7):1755-1761. PubMed ID: 32488563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ovarian reserve before and after chemotherapy.
    Berjeb KK; Debbabi L; Braham M; Zemni Z; Chtourou S; Hannachi H; Hamdoun M; Ayadi M; Kacem K; Zhioua F; Fadhlaoui A; Bahri O; Chakroun N
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102035. PubMed ID: 33307239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
    Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
    Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
    McLaughlin M; Kelsey TW; Wallace WH; Anderson RA; Telfer EE
    Hum Reprod; 2017 Jan; 32(1):165-174. PubMed ID: 27923859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates.
    Sonigo C; Seroka A; Cédrin-Durnerin I; Sermondade N; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1713-9. PubMed ID: 26960957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
    van Beek RD; van den Heuvel-Eibrink MM; Laven JS; de Jong FH; Themmen AP; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Pieters R; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3869-74. PubMed ID: 17726078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease.
    Azem F; Samara N; Cohen T; Ben-Yosef D; Almog B; Lessing JB; Goor O; Amit A
    J Assist Reprod Genet; 2008; 25(11-12):535-8. PubMed ID: 19015974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
    Amin MSA; Brunckhorst O; Scott C; Wrench D; Gleeson M; Kazmi M; Ahmed K
    Clin Transl Oncol; 2021 Jun; 23(6):1067-1077. PubMed ID: 32944834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.
    Decanter C; Morschhauser F; Pigny P; Lefebvre C; Gallo C; Dewailly D
    Reprod Biomed Online; 2010 Feb; 20(2):280-5. PubMed ID: 20113967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study.
    Rosendahl M; Andersen CY; Ernst E; Westergaard LG; Rasmussen PE; Loft A; Andersen AN
    Hum Reprod; 2008 Nov; 23(11):2475-83. PubMed ID: 18635528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
    Anderson RA; Remedios R; Kirkwood AA; Patrick P; Stevens L; Clifton-Hadley L; Roberts T; Hatton C; Kalakonda N; Milligan DW; McKay P; Rowntree C; Scott FM; Johnson PWM
    Lancet Oncol; 2018 Oct; 19(10):1328-1337. PubMed ID: 30220622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
    Behringer K; Thielen I; Mueller H; Goergen H; Eibl AD; Rosenbrock J; Halbsguth T; Eichenauer DA; Fuchs M; Reiners KS; Renno JH; van der Ven K; Kuehr M; von Wolff M; Diehl V; Engert A; Borchmann P
    Ann Oncol; 2012 Jul; 23(7):1818-25. PubMed ID: 22228451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
    Boltežar L; Pintarić K; Jezeršek Novaković B
    J Assist Reprod Genet; 2016 Mar; 33(3):325-333. PubMed ID: 26678493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
    Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield.
    Seshadri T; Gook D; Lade S; Spencer A; Grigg A; Tiedemann K; McKendrick J; Mitchell P; Stern C; Seymour JF
    Br J Cancer; 2006 Apr; 94(7):1007-10. PubMed ID: 16570049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine.
    Machet A; Poudou C; Tomowiak C; Gastinne T; Gardembas M; Systchenko T; Moya N; Debiais C; Levy A; Gruchet C; Sabirou F; Noel S; Bouyer S; Leleu X; Delwail V; Guidez S
    Blood Adv; 2023 Aug; 7(15):3978-3983. PubMed ID: 36129842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.